Long icccentering with tight stop, if trade fails then will look for entry on break of 9.40. sl at 8.58 first tp 9,90. will sell half and trail the rest
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.15 EUR
−2.08 M EUR
25.59 M EUR
5.83 M
About ImmuCell Corporation
Sector
Industry
CEO
Michael F. Brigham
Website
Headquarters
Portland
Founded
1982
ISIN
US4525253062
FIGI
BBG000GS83P8
ImmuCell Corp. engages in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kits, and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME.
Related stocks
BUY: A Micro Cap Company Aiming To Improve The Health Of CattleHere is an idea that I am going to pursue this coming week - feel free to join me.
Let me give you the profile of the company.
Name : ImmuCell Corporation
Sector , Industry, Country: Healthcare | Biotechnology | USA
Plain English Overview :
They create health products, in the form of pills &
IMMUCELL: $5.17 Short Target + Watchlist PotentialFirst off don't take anything I say seriously or at face value, this is an opinion basis. As always, I could be wrong. That being said, let us get into the analysis. Doing a fibonacci-based analysis, I think a conservative medium risk target of $5.17 within the next upcoming weeks is feasible. I als
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ImmuCell Corporation stocks are traded under the ticker IUL.
Yes, you can track ImmuCell Corporation financials in yearly and quarterly reports right on TradingView.
ImmuCell Corporation is going to release the next earnings report on Nov 17, 2025. Keep track of upcoming events with our Earnings Calendar.
IUL net income for the last quarter is 426.05 K EUR, while the quarter before that showed 1.34 M EUR of net income which accounts for −68.15% change. Track more ImmuCell Corporation financial stats to get the full picture.
No, IUL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 3, 2025, the company has 75 employees. See our rating of the largest employees — is ImmuCell Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ImmuCell Corporation EBITDA is 3.77 M EUR, and current EBITDA margin is 3.95%. See more stats in ImmuCell Corporation financial statements.
Like other stocks, IUL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ImmuCell Corporation stock right from TradingView charts — choose your broker and connect to your account.